Growth
Tall Stature
search
Tall Stature
Differential Diagnosis
Normal variants
Constitutional Tall Stature
Familial Tall Stature
Endocrine disorders
Growth Hormone
excess (GH
Secretin
g tumors, pituitary
Gigantism
, or
Cerebral Gigantism
or
Soto Syndrome
)
Obesity
Precocious Puberty
Congenital Adrenal Hyperplasia
(Untreated, pubertal)
Hyperthyroidism
(
Thyrotoxicosis
)
Gene
tic disorders - disproportionate overgrowth
Marfan Syndrome
Homocystinuria
Beckwith-Wiedemann Syndrome
Klinefelter Syndrome
Gene
tic disorders - proportionate overgrowth
Fragile X Syndrome
Cerebral Gigantism
(Sotos Syndrome)
Weaver Syndrome
Evaluation
Assess parental heights
See
Midparental Height
Weight Measurement in Children
Height Measurement in Children
Body Mass Index
Weight for Height Age
See
Dysmorphic features in Congenital Dysorders
Upper to Lower Segment Ratio
Labs
Specific
Insulinlike Growth Factor 1
(IGF-1) - consult local endocrinology
Thyroid Stimulating Hormone
(
Hyperthyroidism
)
Amino Acid
screen (
Homocystinuria
)
Chromosome
Karyotype (
Klinefelter Syndrome
, XXY in males)
Glucose
(Beckwith-Wiedemann)
FSH, LH,
Serum Testosterone
, 17-Hydroxyprogesterone (
Precocious Puberty
,
Congenital Adrenal Hyperplasia
)
Imaging
Bone Age
XRay
Evaluation
Indications for Tall Stature evaluation
Height > 2 SD above mean for age
Projected height >2 SD above
Midparental Height
Normal exam,
Bone Age
and no dysmorphic features
Constitutional Tall Stature
Familial Tall Stature (consistent with
Midparental Height
)
Normal exam without dysmorphic features, but with accelerated
Bone Age
, and recent growth spurt
Obesity
Precocious Puberty
(early sexual characteristics)
Growth Hormone
excess
Hyperthyroidism
Dysmorphic features and proportionate growth
Fragile X Syndrome
Cerebral Gigantism
(Sotos Syndrome)
Weaver Syndrome
Dysmorphic features and dysproportionate growth
Marfan Syndrome
Homocystinuria
Beckwith-Wiedemann Syndrome
Klinefelter Syndrome
Management
Idiopathic Tall Stature
No intervention needed
Older methods have fallen out of favor
High dose sex
Hormone
s promote
Growth Plate
closure, but have significant adverse effects
Growth Plate
destruction (via surgery) is controversial
Pituitary
Gigantism
Growth Hormone
suppression (e.g.
Octreotide
, pegvisomant)
References
Alpert (1998) Pediatr Rev 19(9):303-5 [PubMed]
Barstow (2015) Am Fam Physician 92(1): 43-50 [PubMed]
Cuttler (1987) Pediatrician 14(3):109-20 [PubMed]
Leung (1995) Can Fam Physician 41:457-68 [PubMed]
Nwosu (2008) Am Fam Physician 78(5): 597-4 [PubMed]
Rosenfield (1996) Endocrinol Metab Clin North Am 25:743 [PubMed]
Type your search phrase here